2023 annual financial data
Bolt Biotherapeutics 2023 Operating margin
Bolt Biotherapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was -967.45%.
Operating income was -76,196,000 USD and net income was -69,197,000 USD.
Operating cash flow was -69,525,000 USD.
Get free Bolt Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,876,000 USD
- Operating income
- -76,196,000 USD
- Net income
- -69,197,000 USD
- Operating cash flow
- -69,525,000 USD